Long-acting Injectable Paliperidone Palmitate in a Haemodialysis Patient with Schizophrenia

Jia-Hong Lin,Tsung-Huang Tsai,Chia-Shun Lee,Ya-Hui Yang,Kuang-Peng Chen,Chun-Liong Tung,Jui-Hsiu Tsai

DOI: https://doi.org/10.1177/0004867420952548

2020-01-01

Australian & New Zealand Journal of Psychiatry

Abstract:Australian & New Zealand Journal of Psychiatry, 55(8) possibility that alcohol and cannabis withdrawal were of relevance. The timing of the onset of his disturbance, however, is somewhat later than would be expected if this were the predominant factor. His florid symptoms coincided with an escalation in his usage of the analgesic tramadol and we concluded that this was the predominant causal factor in his psychosis. His usage of desvenlafaxine at a higher dose than prescribed may have further aggravated his condition. The mechanism for psychosis related to tramadol remains unclear; long-term exposure in rat studies revealed significant upregulation of dopamine D2 and D3 receptors in the nucleus accumbens upon repeated treatment with tramadol (FaronGorcka et al., 2004). There are also reports of serotonin norepinephrine reuptake inhibitor–related psychosis in the literature, possibly relating to its dopamine reuptake inhibiting action (Safeekh and Pinto, 2009). Tramadol is a commonly used analgesic and prone to abuse. The Tramadol Consumer Medicine Information leaflet notes ‘confusion’ as a potential, although uncommon, side effect. Prescribing doctors need to be aware of the rare but recognised complication of acute psychosis, particularly when taken at doses in excess of the recommended range.